 "Coronavirus vaccine, Covid-19 vaccine, Covid vaccine")
Zydus Cadila may soon seek emergency use authorization (EUA) for its DNA-plasmid technology-based Covid-19 vaccine from India’s drug regulator. If approved, this would be the first DNA-plasmid vaccine in the world.
This could also be India’s first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator.
India has three Covid vaccines already — Covaxin (Bharat Biotech), Covishield (Serum Institute), and SputnikV (DRL). Sources in the government and the company confirmed that the Ahmedabad-based firm may seek an emergency use authorization from the Drug Controller General of
